Elliott Kieff

39.9k total citations · 7 hit papers
281 papers, 31.9k citations indexed

About

Elliott Kieff is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Elliott Kieff has authored 281 papers receiving a total of 31.9k indexed citations (citations by other indexed papers that have themselves been cited), including 246 papers in Oncology, 146 papers in Pathology and Forensic Medicine and 85 papers in Immunology. Recurrent topics in Elliott Kieff's work include Viral-associated cancers and disorders (243 papers), Lymphoma Diagnosis and Treatment (143 papers) and Parvovirus B19 Infection Studies (70 papers). Elliott Kieff is often cited by papers focused on Viral-associated cancers and disorders (243 papers), Lymphoma Diagnosis and Treatment (143 papers) and Parvovirus B19 Infection Studies (70 papers). Elliott Kieff collaborates with scholars based in United States, United Kingdom and Japan. Elliott Kieff's co-authors include Kenneth M. Izumi, George Mosialos, Richard Longnecker, Alan B. Rickinson, Kenneth M. Kaye, Bernard Roizman, Mark Birkenbach, Jeffrey I. Cohen, Ellen Cahir-McFarland and Eric Johannsen and has published in prestigious journals such as Science, New England Journal of Medicine and Cell.

In The Last Decade

Elliott Kieff

279 papers receiving 30.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epstein-Barr virus and its replication

1996 1.3k citations Elliott Kieff profile →
An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells

1985 1.1k citations David Liebowitz, Elliott Kieff et al. profile →
Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell death

1991 1.0k citations Richard Longnecker, Elliott Kieff et al. profile →
Characterization of Herpes Simplex Virus Strains Differing in their Effects on Social Behaviour of Infected Cells

1968 829 citations Elliott Kieff et al. profile →
Expression of Epstein–Barr Virus Transformation–Associated Genes in Tissues of Patients with EBV Lymphoproliferative Disease

1989 660 citations Lawrence S. Young, Caroline Alfieri et al. New England Journal of Medicine profile →
Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.

1993 645 citations Kenneth M. Izumi, Elliott Kieff et al. Proceedings of the National Academy of Sciences profile →
Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23

1990 496 citations Clare E. Sample, Alan B. Rickinson et al. profile →

Peers

Countries citing papers authored by Elliott Kieff

Since Specialization

Citations

This map shows the geographic impact of Elliott Kieff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elliott Kieff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elliott Kieff more than expected).

Fields of papers citing papers by Elliott Kieff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elliott Kieff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elliott Kieff. The network helps show where Elliott Kieff may publish in the future.

Co-authorship network of co-authors of Elliott Kieff

This figure shows the co-authorship network connecting the top 25 collaborators of Elliott Kieff. A scholar is included among the top collaborators of Elliott Kieff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elliott Kieff. Elliott Kieff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Temporal Proteomic Map of Epstein-Barr Virus Lytic Replication in B Cells 2017 ·Cell Reports ·Ina Ersing, Luís Nobre, Liang Wei Wang, Lior Soday, Yijie Ma, João A. Paulo, Yohei Narita, (unknown), Chang Jiang, Nicholas Grayson, Elliott Kieff, Steven P. Gygi, Michael P. Weekes, Benjamin E. Gewurz	71
2	Epstein-Barr Virus Oncoprotein Super-enhancers Control B Cell Growth 2015 ·Cell Host & Microbe ·Hufeng Zhou, (unknown), Sizun Jiang, (unknown), Katharina Bernhardt, Jun Liang, Eric Johannsen, Peter V. Kharchenko, Benjamin E. Gewurz, Elliott Kieff, Bo Zhao	136
3	The PP4R1 subunit of protein phosphatase PP4 targets TRAF2 and TRAF6 to mediate inhibition of NF-κB activation 2014 ·Cellular Signalling ·(unknown), Hasem Habelhah, Elliott Kieff, George Mosialos, Eudoxia Hatzivassiliou	21
4	A Vibrio parahaemolyticus T3SS Effector Mediates Pathogenesis by Independently Enabling Intestinal Colonization and Inhibiting TAK1 Activation 2013 ·Cell Reports ·Xiaohui Zhou, Benjamin E. Gewurz, Jennifer M. Ritchie, Kaoru Takasaki, Hannah Greenfeld, Elliott Kieff, Brigid M. Davis, Matthew K. Waldor	71
5	EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding 2011 ·Proceedings of the National Academy of Sciences ·(unknown), Bo Zhao, Michael A. Calderwood, Thomas Sommermann, Eric Johannsen, Elliott Kieff	34
6	Latent Membrane Protein 1 Is Dispensable for Epstein-Barr Virus Replication in Human Embryonic Kidney 293 cells 2011 ·PLoS ONE ·Vicki Geiser, Ellen Cahir-McFarland, Elliott Kieff	8
7	Genetic Analysis of Human Traits In Vitro: Drug Response and Gene Expression in Lymphoblastoid Cell Lines 2008 ·PLoS Genetics ·Edwin Choy, Roman Yelensky, (unknown), Robert M. Plenge, Richa Saxena, Philip L. De Jager, Stanley Y. Shaw, (unknown), Jacqueline M. Slavik, Chris Cotsapas, Manuel A. Rivas, Emmanouil T. Dermitzakis, Ellen Cahir-McFarland, Elliott Kieff, David A. Hafler, Mark J. Daly, David Altshuler	164
8	Pim kinases are upregulated during Epstein–Barr virus infection and enhance EBNA2 activity 2005 ·Virology ·Eeva-Marja Rainio, Helena Ahlfors, Kara Carter, (unknown), Sampsa Matikainen, Elliott Kieff, Päivi J. Koskinen	30
9	Effects of the NIK aly Mutation on NF-κB Activation by the Epstein-Barr Virus Latent Infection Membrane Protein, Lymphotoxin β Receptor, and CD40 2001 ·Journal of Biological Chemistry ·Micah A. Luftig, Ellen Cahir-McFarland, George Mosialos, Elliott Kieff	38
10	Intracellular forms of human NOTCH1 interact at distinctly different levels with RBP-Jkappa in human B and T cells 2000 ·Leukemia ·Jennifer Callahan, Jon C. Aster, Jeffrey Sklar, Elliott Kieff, (unknown)	8
11	EPSTEIN-BARR VIRUS-INDUCED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS 1999 ·Transplantation ·Carlos V. Payá, John J. Fung, Michael A. Nalesnik, Elliott Kieff, Michael Green, (unknown), Thomas M. Habermann, Russell H. Wiesner, Lode J. Swinnen, E. Steve Woodle, Jonathan S. Bromberg	387
12	In vivo growth of Epstein-Barr virus transformed B cells with mutations in latent membrane protein 2 (LMP2) 1997 ·Archives of Virology ·Rosemary Rochford, Cathy L. Miller, Martin J. Cannon, Kenneth M. Izumi, Elliott Kieff, Richard Longnecker	18
13	The Epstein-Barr Virus Nuclear Protein 2 Acidic Domain Forms a Complex with a Novel Cellular Coactivator That Can Interact with TFIIE 1995 ·Molecular and Cellular Biology ·Tong Xiao, Ronny Drapkin, Ramana R. Yalamanchili, George Mosialos, Elliott Kieff	215
14	Integral membrane protein 2 of Epstein—barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases 1995 ·Immunity ·(unknown), Anne L. Burkhardt, (unknown), (unknown), Richard Longnecker, Joseph B. Bolen, Elliott Kieff	260
15	A Novel Epstein-Barr Virus Glycoprotein gp150 Expressed from the BDLF3 Open Reading Frame 1995 ·Virology ·Michael G. Kurilla, Thomas C. Heineman, L. Davenport, Elliott Kieff, Lindsey Hutt‐Fletcher	20
16	Early events in Epstein-Barr virus infection of human B lymphocytes 1991 ·Virology ·Caroline Alfieri, Mark Birkenbach, Elliott Kieff	239
17	Subnuclear localization and phosphorylation of Epstein-Barr virus latent infection nuclear proteins 1990 ·Virology ·Lisa M. Petti, Clare E. Sample, Elliott Kieff	108
18	10 Oncogenesis by Herpesviruses 1989 ·Cold Spring Harbor Monograph Archive ·Elliott Kieff, David Liebowitz	0
19	Expression of Epstein–Barr Virus Transformation–Associated Genes in Tissues of Patients with EBV Lymphoproliferative Disease breakdown → 1989 ·New England Journal of Medicine ·Lawrence S. Young, Caroline Alfieri, Kathleen Hennessy, Helen Evans, Carl O’Hara, KS Anderson, Jerome Ritz, Ralph Shapiro, Alan B. Rickinson, Elliott Kieff, (unknown)	660
20	Characterization of N- and O-linked oligosaccharides of glycoprotein 350 from Epstein-Barr virus 1989 ·Virology ·Franca Serafini‐Cessi, Nadia Malagolini, (unknown), Fabio Dall’Olio, Gabriella Campadelli‐Fiume, Jerome E. Tanner, Elliott Kieff	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact